International Vaccination & Capacity Workshop 2019 




May 22, 2019 from 8.30 a.m. to 5 p.m. 


Campus Biotech, 9 chemin des mines 

1202 Geneva, Switzerland


Participation is FREE but Registration is mandatory

To Participate click here 

Hurry up, Limited Seats Available 

















After the success of its 2018 “International Global Health & Antimicrobial Resistance Workshop”, the World Federation of Public Health Associations (WFPHA) is pleased to announce its 2019 “International Vaccination & Capacity Workshop”.

The workshop will discuss strategies and good practices to increase primary prevention through increased capacity (from human to infrastructures to sustainable investments and beyond) applied to the vaccination context.

Notwithstanding the scientific evidence of the safety and effectiveness of vaccines, we continue to witness major outbreaks and deaths from vaccine-preventable diseases. The reasons are complex and vary between and within geographical regions and countries. These reasons include lack of health care access, resource constraints, population displacement due to war and violence, religious opposition, vaccine refusal, conspiracy theories, and philosophical reasons on the ethics and politics of mandatory vaccination.

Human Resources for Health (HRH) are at the core of “capacity”, which is an essential element of the Global Charter for the Public’s Health. Although there is increasing recognition that HRH are essential for the achievement of broader development goals, including Universal Health Coverage, we face a global crisis. This crisis is characterised by: sub-optimal leadership and governance; inequitable distribution; widespread shortages; poor performance; and lack of responsiveness to the needs of communities. The suboptimal resources for health are not limited to HRH only but embrace also infrastructures, institutional capacity, and strategic investment.

The WFPHA is taking the lead in enhancing the discourse on vaccination and capacity to enable its members, partners and stakeholders to increase their knowledge and advocacy efforts on these important global priorities. The workshop discussions will feed into the deliberations of civil society in the lead up to the United Nations Assembly in September 2019 on Universal Health Coverage.

Confirmed speakers

               Confirmed Speakers

Screen Shot 2019 04 15 at 10.09.10 AMScreen Shot 2019 04 15 at 10.09.10 AM

Speakers' biographies

Richard J. Hatchett, MD, Chief Executive Officer of CEPI

Richard J. Hatchett, MD, is Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership of public, private, philanthropic and civil organizations that will finance and co-ordinate the development of vaccines against high priority public health threats and vaccine platform technologies to respond rapidly to emerging infectious diseases with pandemic or epidemic potential. Dr. Hatchett most recently served as acting Director of the U.S. Biomedical Advanced Research and Development Authority (BARDA), after serving for five years as BARDA’s Chief Medical Officer and Deputy Director. At BARDA, Dr. Hatchett oversaw programs to develop medical countermeasures against chemical, biological, radiological and nuclear threats, pandemic influenza, and emerging infectious diseases and led or helped lead the development of vaccines, therapeutics, and diagnostics for a number of emerging viruses. Dr. Hatchett has served on the White House Homeland Security Council under President George W. Bush and was a member of the White House National Security Staff under President Barack Obama. He is a recipient of the HHS Secretary’s Award for Distinguished Service and a five-time recipient of the NIH Director’s Merit Award. A graduate of Vanderbilt University, he completed a residency in internal medicine at the New York Hospital – Cornell Medical Center and a fellowship in medical oncology at Duke University Medical Center.  

Julia Spencer, Executive Director at Merck & Co, Inc. 

Julia Spencer is the appointed Executive Director for Global Vaccines Public Policy, Partnerships, and Government Affairs at MSD. She leads global public policy and advocacy to expand access to Merck vaccines and develops policy strategy to achieve maximum population health impact and business growth. Dr. Spencer has over 25 years of public health and health policy experience at the local, state, national, and international levels. She joined MSD in 2014 as the lead for International Vaccines Public Policy, overseeing the formation of an international focused policy team charged with strengthening partnerships and developing new platforms for evidence-based policy engagement on critical vaccine issues. Dr. Spencer served for 15 years as a senior health official in the US Department of Health and Human Services (HHS) and served as the Science Policy Director within the Secretary’s policy, planning, and evaluation office (ASPE). She was responsible for policy coordination and legislative development focused on the HHS science agencies. She has led the creation of two 5-year HHS Strategic Plans, the first HHS Global Health Strategy, and the Health System Measurement Project; developed a new HHS-wide evaluation capacity development initiative; and served as a senior policy analyst in the US CDC Rwanda Office. Prior to joining ASPE, she spent six years working on tobacco policy and substance abuse prevention efforts with HHS’s Substance Abuse and Mental Health Services Administration. Finally, she holds a Doctor of Philosophy degree in public health. 

Jon Wardle, Associate Professor of Public Health at the University of Technology Sydney

Jon Wardle is an Associate Professor of Public Health at the University of Technology Sydney and heads the Regulatory, Legislative and Policy Stream at the Australian Research Centre in Complementary and Integrative Medicine, where he holds a prestigious National Health and Medical Research Council Research Translation Fellowship aimed at increasing vaccines. In addition to his clinical qualifications in nursing and naturopathy, Jon has postgraduate qualifications in public health, law and health economics and holds visiting positions at the Schools of Medicine at University of Washington and Boston University. Jon has published more than 120 peer-reviewed journal articles, 20 academic book chapters and 4 academic books, and serves on the editorial board of 8 international academic journals. Jon is co-convener of the Public Health Association of Australia’s Complementary Medicine Special Interest Group, is part of the executive of the American Public Health Association Integrative Health Section Policy Committee and has been an advisor on this issue to the WHO. Jon is actively involved in the PHAA Research Advisory Group and Parliamentary hearings on topics such as food and nutrition, practitioner regulation and health law. Jon has worked on traditional medicine, public health and primary health care policy and regulatory initiatives with numerous governments, non-government organisations and international bodies

Lois Privor-Dumm, Director of Policy, Advocacy & Communications at IVAC

Lois Privor-Dumm is the Director of Policy, Advocacy & Communications (PAC) at the International Vaccine Access Center (IVAC) at Johns Hopkins Bloomberg School of Public Health. She leads PAC team efforts on a variety of projects at country, regional, and global level, including advocacy and capacity building in low- and middle- income countries and policy research and advocacy for adult vaccines. She also works on new vaccine introduction support for pneumococcal, rotavirus, and HPV, advice and training on vaccine confidence, and the communication of evidence to establish the broader value of vaccines through IVAC’s VoICE tool. Prior to joining Hopkins, she worked nearly 18 years in the private sector with roles in marketing, finance, and regional operations, most notably launching the pneumococcal conjugate vaccine in the US and supporting other countries in Latin America and Europe. She holds a Master of International Business Studies from the University of South Carolina.

Dr. Irina Ljungqvist, Senior Expert Pubic Health Capacity at ECDC

Irina Ljungqvist is a Senior Expert Pubic Health Capacity at the European Centre for Disease Prevention and Control (ECDC) in Sweden. She is a public health physician with a PhD in Public Health with more than 25 years experience in health communication, health policy, and public health. Her current projects include workforce capacity strengthening for EU Member States in communicable diseases prevention and control, focusing on increasing vaccine acceptance through training healthcare professionals, capacity strengthening in infection prevention and control and hospital acquired infections. She also worked bridging evidence with policy and practice, core competencies for field epidemiologists and microbiologists. In the past, Dr. Ljungqvist hasworked for John Snow, Inc. on a large-scale program on sexual and reproductive health in Romania and Eastern Europe being responsible for policy and behavior change areas, coordinated health promotion activities in Romania, and set up a NGO on delivering sexual and reproductive health education for young people using peer education in Romania - "Youth for Youth Foundation".

Adrian Te Patu, Member of the Governing Council at WFPHA

Adrian Te Patu is an active member of the Governing Council at WFPHA where he represents New Zealand and the Asia-Pacific region. He is the first indigenous member of the council. For over three decades, Mr. Te Patu has worked for government departments, crown agencies, community organizations, Iwi, District Health Board's and other health providers. He has also been a member of various government reference groups and has had numerous board and governance roles. In more recent years, Mr. Te Patu has worked as a tutor, trainer and advisor in public health, health promotion and indigenous health. He is a Maori Caucus member and Co-Vice President of the Public Health Association of New Zealand. In addition, Mr. Te Patu served on the board of the Health Promotion Forum of New Zealand and served two terms as an elected member of the Christchurch City Council on the Lyttelton Mt. Herbert Community Board.

Dr. Wanderson Kleber de Oliveira, Secretariat of Health Surveillance for the Ministry of Health Brazil

Dr. Wanderson Kleber de Oliveira is an Epidemiologist in Brazil and works as the Secretariat of Health Surveillance for the Ministry of Health of Brazil. He received his PhD in Epidemiology from the Federal University of Rio Grande do Sul (UFRGS). As an Epidemiologist with 21 years of professional experience, he has worked in areas of public health, health surveillance, prevention and control of diseases, family health, therapeutic home care, and emergency management in public health. At the Oswaldo Cruz Foundation (Fiocruz) in Brazil, Dr. Wanderson develops research and manages actions with the Center for Data Integration and Knowledge for Health (CIDACS), works on Zika surveillance, and acts as a coordinator and teacher of the Nucleus of Epidemiology and Surveillance in Health. For 15 years, Dr. Oliveira has worked for the Ministry of Health where he coordinated the national response to the influenza pandemic and Congenital Zika Syndrome. In addition, he was responsible for the International Health Regulations (IHR) at mass events such as the World Cup and the Olympics.

Dr. Viviana Martinez-Bianchi, MD, Family Doctor

Viviana Martinez-Bianchi, MD, FAAFP is a member of the executive board of the World Organization of Family Doctors (WONCA) and Liaison to the World Health Organization. She is the Program Director of the Family Medicine Residency Program, at Duke University's Department of Family Medicine and Community Health in Durham, North Carolina, USA. She is chair of the Health Equity Team for Family Medicine for America's Health, and the Organizational Equity Committee of WONCA.  Her work addresses family doctors’ clinical education, teamwork, and interprofessional education. As a clinician she practices family medicine, caring for the whole family, from prenatal care to end of life, prevention, chronic disease management, community health, addressing social determinants of health and improving health equity. 

Ms. Malebona Precious Matsoso, Director General of the South African Department of Health

Ms. Malebona Precious Matsoso is the Director General of the National Department of Health in South Africa, appointed by the President of South Africa on 08 June 2010. She manages health issues for the entire country, as well as reporting to and advising the Health Ministry. Ms. Matsoso holds a degree in Pharmacy from the University of Western Cape, a Postgraduate Diploma in Health Management from the University of Cape Town, and a Masters degree in Law and Ethics (LLM) from the University of Dundee. As a pharmacist she has worked in both the public and private sector at management level. Ms. Matsoso has experience serving as the Registrar of Medicines of the National Drug Regulatory Authority in South Africa and as Secretariat of the Southern African Development Community (SADC). Ms. Matsoso was a Director in Public Health, Innovation and Intellectual Property (PHI) in the office of the Director General of the World Health Organisation (WHO). Her career within the field of medicine control has included posts as Head of Medicines Control Council (MCC) for seven years overseeing 10 technical committees, member of the National Research Ethics Council of South Africa, and Director of the Essential Drugs and Traditional Medicines Programme. She has also been a member of various advisory panels with an emphasis on improving access to medicines and anti-retrovirals.

Samantha Vanderslott, Postdoctoral Researcher at the University of Oxford

Dr. Samantha Vanderslott is a social sciences researcher at the University of Oxford working on health, society, and policy topics. She completed her PhD in the STS Department on the policy development for 'Neglected Tropical Diseases' at the University College London in 2017, after working as a senior policy advisor in the UK Civil Service. In 2016, Dr. Vanderslott joined the Oxford Vaccine Group as a Social Science Researcher as part of the Oxford Martin School Programme "The Human Factor: Infectious Disease and Collective Responsibility". She is also a Junior Researcher Fellow at Linacre College. With a background in global governance, international development, and scientific studies, Dr. Vanderslott draws on perspectives from sociology, history, global public health, and science and technology studies. In addition to her academic and research work, she has published in journals including "Social Science and Medicine", "Infectious Diseases of Poverty", and "Human Development and Capabilities". Her current projects focus on attitudes to vaccination, policies for neglected tropical diseases, past and present challenges of typhoid, and health research during outbreaks. 

Badr Elsheikh Elsiddig, President of the Sudanese Public Health Association (SPHA)

Elsheikh Badr is a transformational health leader with track record in revitalization and reform of key health system institutions in Sudan. He is a medical doctor by profession and qualified in community medicine, public health, and health system management from Sudan and the UK. He developed his specialism as health system and health workforce expert and consultant.  He has served as Secretary General for the Sudan Medical Specialization Board (SMSB), the prime postgraduate medical education and training body in the country. Dr Badr has major contribution to health system strengthening throughout his 22 years’ experience in professional, managerial and leadership roles including senior posts at Federal Ministry of Health in Sudan. He has wide regional and international involvement and contributions. He served as WHO and EU consultant several times and was selected to regional and international committees through WHO and other world leading entities. He currently sits on the International Conference Committee for organization of the 16th World Congress on Public Health in Rome 2020. 

Borisch Bettina, Professor of Social and Preventive Medicine, University of Geneva

Dr Borisch is an MD and a Histopathologist, MPH and Fellow of the Royal College of Pathology (UK). Her scientific research work delves into neoplastic lesions of the immune system and breast cancer. Her interests also include community-based oncology, as well as health communication and global health. She is the Editor in Chief of “Pathobiology” and the Co-Editor of “Journal of Public Health Policy”. In addition to her academic work she is the Director of the World Federation of Public Health Associations Headquarter and helds positions at several Committees of Public Health oriented institutions. She was president of Europa Donna – The European Breast Cancer Forum – and Founding President of the Swiss Forum of Europa Donna. She teaches at the University of Geneva, the Swiss School of Public Health and she also teaches patient support groups. She is author of over 120 scientific papers and 2 books.

Krech Rüdiger, Director for Universal Health Coverage and Health Systems at the World Health Organization

Rüdiger Krech is the Director for Universal Health Coverage and Health Systems at the World Health Organization. The cluster of Universal Health Coverage (UHC) covers WHO’s work in the areas of integrated people-centered health services, health workforce, financing and health governance. As his function is positioned in the Assistant Director-General’s Office, he acts on behalf of, and represents her in meetings, committees and other events and facilitates coordination and coherence between the health systems work of the Organization and other areas of public health. He is the cluster’s focal point for the WHO transformation, in particular on issues relating to WHO leadership priorities, governance and management. Before that, Dr Krech was the Director of the Department of Ethics, Equity, Trade and Human Rights at the World Health Organization from 2009 to 2012. In this capacity, he was also responsible for WHO’s work on Social Determinants of Health and Health in All Policies.

Moore Michael, Past CEO of Public Health Association of Australia

Michael Moore e is the chair of a number of health networks. He is a former Minister of Health and Community Care and was an Independent member of the Australian Capital Territory Legislative Assembly for four terms from 1989 to 2001. He was Australia’s first independent Minister when he was appointed as Minister of Health and Community Care. Professor Moore is a former teacher, small business owner and consultant who holds a post-graduate diploma in education, a master’s degree in population health from the ANU, is a Visiting Professor at the University of Technology Sydney, and an adjunct professor with the University of Canberra where he is a PhD Scholar examining a framework for planning or evaluating health advocacy. He is widely published. He is also a political and social columnist who has served on a range of academic and community Boards. Michael Moore also is the Immediate pas President of the World Federation of Public Health Associations. 

Ricciardi Walter, Professor of Hygiene and Public Health at the Catholic University of the Sacred Heart in Rome

Walter Ricciardi is Professor of Hygiene and Public Health at the Catholic University of the Sacred Heart in Rome. In August 2015 Walter Ricciardi was appointed President of the Italian National Institute of Health (Istituto Superiore di Sanità) where he was Commissioner from 2015 to 2018. In 2003 he was appointed President of the European Public Health Association (EUPHA), in 2010 he was elected President again and in 2011 he was re-elected for a second term up to 2014. Since 2014 he is Past President of EUPHA. In December 2015, he was appointed Director of the WHO Collaborating Centre for Health Policy, Governance and Leadership at the Institute of Public Health, Medical School, Catholic University of the Sacred Heart – Rome. In November 2017 he was appointed Member of the Executive Board of the World Health Organization.

Rispel Laetitia, Professor of Public Health at the University of the Witwatersrand in Johannesburg, South Africa

Laetitia Rispel has extensive and wide-ranging experience of research, teaching, and health leadership in different settings, and has published extensively on different aspects of health policy and the transformation of the South African health system. She has won several national and international awards, including the South African Shoprite/Checkers/SABC2 woman of the year award in the health category (2003); International Nurse Researcher Hall of Fame of the Sigma Theta Tau Nursing Honors Society (2013); Gauteng branch of the South African Medical Association award in the allied category (2013); University vice-chancellor’s academic citizenship award (2014); Academy of Science of South Africa membership award (2015). Since 2018, she is the President of the World Federation of Public Health Associations, the first African woman in the 50 year history of the organisation to achieve this honour. 


Sponsors and Supporters

Thank you to our sponsors!

bronze sponsorsbronze sponsors other sponsorssother sponsorss

If you are interested in sponsoring this event, please click here



Campus Biotech

9 Chemin des Mines

1202 Geneva


Key contacts

  • Marta Lomazzi, PhD 
    Executive Manager 
    World Federation of Public Health Associations 
    Tel: +41 22 3790455 
  • Eleonora De Cata, PhD
    Office Manager
    World Federation of Public Health Associations
    Tel: +41 22 3790484


Coming soon 

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedInShere with friendsDisplay print-friendly version